My Steps for Healthy Living – Report Card

Where "My Steps" walkers record their progress

This page is for My Steps for Healthy Living registrants only. If you are not currently registered for the program, please do so before filling out the report card. Register now.

The "My Steps" report card is a convenient, online form where you can record and track your fitness progress from month to month.

  • Use this report card to set goals and stay motivated
    • Start walking on the first day of the month
    • Complete an online report card on the last day of the month

Instructions for using the online report card

  1. On Day 1, put on your pedometer as soon as you get up.

  2. At the end of the first day, record the number of steps you walked on your log sheet. This sheet has been designed to make it easy for you to log your totals from each day for an entire month.

    Your goal is to increase the number of steps you take by 10% from the first day of the month to the last day of the month. For example, if on March 1 you walk 2,000 steps, your goal is to walk 2,200 steps on March 31 – an increase of 10%. If you aren't able to increase your steps by 10% in a month, don't worry – and don't give up! Remember: You don't have to walk fast or for long periods of time to benefit!

  3. At the end of the month, add up the steps you recorded on your log sheet throughout the month, enter the total on the My Steps for Healthy Living Report Card below, and click Submit.
  4. Once your submission is processed, you will receive a motivational reward. It is our way of congratulating you on a job well done.

    5. Download a printable copy of the "My Steps" Log Sheet

Please complete the fields below to submit your steps for the month

  • Fields marked with an asterisk (*) are required.
  •  
Verification Code

Prior to submitting your information, please review our Privacy Policy.

Important Safety Information

Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated for chronic augmentation and maintenance therapy for adults with alpha1-proteinase inhibitor (A1-PI) deficiency and emphysema. Clinical data demonstrating the long-term effects of chronic augmentation therapy with Zemaira are not available.

Zemaira may not be appropriate for the following adult individuals as they may experience severe reactions, including anaphylaxis: individuals with a known hypersensitivity and/or history of anaphylaxis or severe systemic reaction to A1-PI products or their components, and individuals with selective IgA deficiencies who have known antibodies against IgA.

In clinical studies, the following treatment-related adverse reactions were reported in 1% of subjects: asthenia (fatigue), injection-site pain, dizziness, headache, paresthesia (tingling), and pruritus (itching).

Zemaira is derived from human plasma. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Please see full prescribing information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Do you want to continue?

No Yes